Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022 - Hologi
New Affirm Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment and Monitoring Solutions on Display
Hologic, Inc. HOLX will exhibit its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec. 1. Among the full suite of breast biopsy and surgery solutions will be Hologic's Affirm Contrast Biopsy software, which will be on display for the first time since becoming commercially available in the United States.
As the global leader in breast imaging, we are committed to addressing the unmet needs of physicians and their patients across the continuum of breast care and we're eager to engage with industry leaders at this year's RSNA meeting to share our vision for the future of breast health, said Erik Anderson, President of Hologic's Breast and Skeletal Health Solutions Division. We are equally excited to showcase our new Affirm Contrast Biopsy technology, which is a great example of our commitment to physicians and patients in action.
Continue read on benzinga.com